References
Cooper JF, Foti A (1974) A radioimmunoassay for prostatic acid phosphatase. I. Methodology and range of normal male serum values. Invest Urol 12:98
Shaw LM, Yang N, Neat M, Croop W (1982) Immunological and clinical specificity of the immunological determination of prostatic acid phosphatase. Ann Rev NY Acad Sci 390:73
Papsidero LD, Wang WC, Valenzuela LA, Murphy GP, Chu TM (1980) A prostate antigen in sera of prostatic cancer patients. Cancer Res 40:2428
Kuriyama M, Wang MC, Lee CL, Killian CS, Papsidero LD, Inaji H, Loor RM, Lin MF, Nishiura T, Slack NH, Murphy GP, Chu TM (1982) Multiple marker evaluation in human prostate cancer with the use of tissue specific antigen. JNCI 68:75
Huber PR, Zaugg T, Linder E, Hagmaier V, Rutishauser G (1982) Creatine kinase isoenzyme (CKBB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer. Urol Res 10:75
Huber PR, Rist M, Hering F, Biedermann C, Rutishauser G (1983) Tissue polypeptide antigen (TPA) and prostatic acid phosphatase in serum of prostatic cancer patients. Urol Res 11:223
Pontes JE (1983) Biological markers in prostate cancer. J Urol 130:1037
Huber PR, Scholer A, Linder E, Hagmaier V, Vogt H, Christen P, Eppenberger U, Rutishauser G (1982) Measurement of prostatic acid phosphatase in serum and bone marrow: radioimmunoassay and enzymic measurement compared. Clin Chem 28:2044
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Huber, P.R. Marker substances and prostate cancer. Urol. Res. 12, 231–232 (1984). https://doi.org/10.1007/BF00256145
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00256145